| 11 |
[HitNews] 4 Companies Including Elimis Therapeutics Selected for 'Korea-Switzerland BioPass'
장 수환
|
2026.06.25
|
Votes 0
|
Views 42
|
장 수환 |
2026.06.25 |
0 |
42 |
| 10 |
[Newsis] K-Bio Global Expansion Support — Roche Korea Holds Award Ceremony
장 수환
|
2026.06.25
|
Votes 0
|
Views 38
|
장 수환 |
2026.06.25 |
0 |
38 |
| 9 |
[Newsis] Korean Roche Holds Awards Ceremony to Support K-Bio Global Expansion
장 수환
|
2026.06.09
|
Votes 0
|
Views 44
|
장 수환 |
2026.06.09 |
0 |
44 |
| 8 |
[HitNews] Four Companies Including Illumis Therapeutics Selected for Korea-Switzerland BioPass
장 수환
|
2026.06.09
|
Votes 0
|
Views 46
|
장 수환 |
2026.06.09 |
0 |
46 |
| 7 |
[Survivant Biologics] Stock Split and Share Submission Notice
장 수환
|
2026.06.09
|
Votes 0
|
Views 46
|
장 수환 |
2026.06.09 |
0 |
46 |
| 6 |
[Bktimes] 4 K-Bio Companies Beat 100-to-1 Competition — Chosen by Roche to Secure Switzerland Entry Tickets
장 수환
|
2026.06.08
|
Votes 0
|
Views 2475
|
장 수환 |
2026.06.08 |
0 |
2475 |
| 5 |
[K-Health] Roche Korea Holds Award Ceremony for Korea-Switzerland BioPass Selected Companies
장 수환
|
2026.06.08
|
Votes 0
|
Views 53
|
장 수환 |
2026.06.08 |
0 |
53 |
| 4 |
[The Bio] Antibodies Targeting Cancer Cells Discovered from Blood of Cancer Survivors — Challenging First-in-Class Drug Develop
장 수환
|
2026.06.08
|
Votes 0
|
Views 86
|
장 수환 |
2026.06.08 |
0 |
86 |
| 3 |
Professor Huiping Liu from Northwestern University visit Survivant Biologics on 8th Aug
chang
|
2025.08.02
|
Votes 1
|
Views 579
|
chang |
2025.08.02 |
1 |
579 |
| 2 |
Survivant biologics won a local grant from Ulsan City
jang
|
2025.07.08
|
Votes 1
|
Views 495
|
jang |
2025.07.08 |
1 |
495 |
